Home > Healthcare > Medical Devices > Diagnostic Devices > Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market Share
- Report ID: GMI5597
- Published Date: May 2023
- Report Format: PDF
Infectious Disease Diagnostics Market Share
- Abbott Laboratories
- BioMerieus SA
- Becton Dickinson and Company
- Danaher Corporation
- Bio-Rad Laboratories
- F Hoffman-La Roche
- Hologic Inc
- Qiagen Inc
- Siemens Healthineers,
- Thermo Fisher Scientific Inc
are some of the leading infectious disease diagnostics industry market participants worldwide. These firms are actively adopting various strategies to boost their revenue sales.
Frequently Asked Questions (FAQ) :
Global market for Infectious disease diagnostics was USD 24 billion in 2022 and will exhibit more than 5.5% CAGR from 2023-2032 due to the increasing preference for point-of-care diagnostic testing.
Respiratory disease applications will record 6% CAGR from 2023-2032 owing to the significant rise in the number of pathogens that cause respiratory infections include bacteria, viruses, fungi, and parasites.
North America infectious disease diagnostics market is estimated to exceed USD 17 billion by 2032 due to the surging frequency of infectious diseases and the scaling deployment of cutting-edge diagnostic technologies.
Abbott Laboratories, BioMerieus SA, Becton Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, F Hoffman-La Roche, Hologic Inc., Qiagen Inc., Siemens Healthineers, and Thermo Fisher Scientific Inc. are some infectious disease diagnostic companies. ?
Infectious Disease Diagnostics Market Scope
×
Get a free sample of
Infectious Disease Diagnostics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below